1. Home
  2. CEPU vs SUPN Comparison

CEPU vs SUPN Comparison

Compare CEPU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Puerto S.A. (each represents ten)

CEPU

Central Puerto S.A. (each represents ten)

HOLD

Current Price

$16.73

Market Cap

2.6B

Sector

Utilities

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$51.51

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEPU
SUPN
Founded
1989
2005
Country
Argentina
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
CEPU
SUPN
Price
$16.73
$51.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.50
$61.60
AVG Volume (30 Days)
414.1K
474.4K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$10.11
$22.72
Revenue Next Year
N/A
$18.10
P/E Ratio
$12.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.43
$29.16
52 Week High
$18.50
$59.68

Technical Indicators

Market Signals
Indicator
CEPU
SUPN
Relative Strength Index (RSI) 58.14 53.28
Support Level $14.84 $47.43
Resistance Level $18.22 $52.14
Average True Range (ATR) 0.79 1.62
MACD 0.17 0.18
Stochastic Oscillator 79.53 81.02

Price Performance

Historical Comparison
CEPU
SUPN

About CEPU Central Puerto S.A. (each represents ten)

Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: